Statement Of Cash Flows [Abstract]

STADA Arzneimittel AG - Filing #6743034

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
321,273 EUR
245,239 EUR
Adjustments for undistributed profits of investments accounted for using equity method
268,000 EUR
93,000 EUR
Income taxes paid, classified as operating activities
61,664 EUR
63,892 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations
- EUR
231,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.